Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopic features can help distinguish female androgenetic alopecia from telogen effluvium and healthy controls.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

A simple wash test can help differentiate between two types of hair loss, and dermatoscopy should be used for further clarification.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

Hair count is important to distinguish between genetic hair thinning (Androgenetic Alopecia) and hair thinning caused by disrupted hair growth (Chronic Telogen Effluvium).

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

CTE can distort results in hair growth trials, so exclude it carefully.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Trichoscopy is not specific for diagnosing telogen effluvium and both telogen effluvium and androgenetic alopecia often occur together.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

A woman was misdiagnosed with hair loss for years, but actually had a rare type of alopecia.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

COVID-19 may cause temporary hair loss in some people.

Finasteride may not stop severe hair loss after stopping minoxidil.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Some people with chronic hair loss may have thyroid autoimmunity.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

PRP shows promise for short-term hair growth, especially in young men.